Breast Cancer Drug Study Canceled

The federal government canceled a $100 million study designed to test a new generation of drugs to prevent breast cancer in women at risk for the disease. The National Cancer Institute took the unusual step of terminating the long-planned study, saying the massive project could not be justified amid questions about the study's usefulness and the drugs' safety. The decision was criticized by proponents, who argued that the study would have been crucial to determining the best drugs to prevent breast cancer, potentially protecting thousands of women from the common malignancy. Full story...

Posted by Editor at June 22, 2007 06:19 AM